MedPath

成都迪康药业股份有限公司

Ownership
-
Established
2015-01-09
Employees
-
Market Cap
-
Website
https://dkyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

93

NMPA:93

Drug Approvals

Enoxacin Dispersible Tablets

Product Name
依诺沙星分散片
Approval Number
国药准字H20080817
Approval Date
Oct 23, 2023
NMPA

增抗宁胶囊

Approval Number
国药准字Z20080060
Approval Date
Jan 9, 2023
NMPA

Lotio Acidi Borici

Product Name
殷泰
Approval Number
国药准字H51023539
Approval Date
Aug 17, 2022
NMPA

Prucalopride Succinate Tablets

Product Name
琥珀酸普芦卡必利片
Approval Number
国药准字H20213915
Approval Date
Nov 30, 2021
NMPA

Prucalopride Succinate Tablets

Product Name
琥珀酸普芦卡必利片
Approval Number
国药准字H20213914
Approval Date
Nov 30, 2021
NMPA

Apixaban Tablets

Product Name
阿哌沙班片
Approval Number
国药准字H20213888
Approval Date
Nov 24, 2021
NMPA

Ticagrelor Tablets

Product Name
替格瑞洛片
Approval Number
国药准字H20203737
Approval Date
Dec 29, 2020
NMPA

Erythromycin Ethyisuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H51023174
Approval Date
Nov 18, 2020
NMPA

Inosine Oral Solution

Product Name
肌苷口服液
Approval Number
国药准字H50021246
Approval Date
Nov 18, 2020
NMPA

Spiritus Camphorae

Product Name
樟脑醑
Approval Number
国药准字H50021253
Approval Date
Nov 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.